Literature DB >> 26696791

Stereotactic Body Radiation Therapy: A useful weapon in anticancer treatment.

M Scorsetti1.   

Abstract

Year:  2015        PMID： 26696791      PMCID： PMC4661352          DOI： 10.1016/j.rpor.2015.07.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN： 1507-1367


× No keyword cloud information.
  19 in total

1.  SBRT and extreme hypofractionation: A new era in prostate cancer treatments?

Authors:  Filippo Alongi; Alba Fiorentino; Berardino De Bari
Journal:  Rep Pract Oncol Radiother       Date:  2014-10-22

Review 2.  Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?

Authors:  Stefano Arcangeli; Linda Agolli; Vittorio Donato
Journal:  Rep Pract Oncol Radiother       Date:  2014-09-10

Review 3.  Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice.

Authors:  Robert D Timmerman; Joseph Herman; L Chinsoo Cho
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

4.  Local failure after primary radiotherapy in lung cancer: Is there a role for SBRT?

Authors:  Beatriz E Amendola; Marco A Amendola; Naipy Perez; Xiaodong Wu; Jesús Blanco Suarez
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

Review 5.  Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.

Authors:  Po-Ming Wang; Na-Na Chung; Wei-Chung Hsu; Feng-Ling Chang; Chin-Jyh Jang; Marta Scorsetti
Journal:  Rep Pract Oncol Radiother       Date:  2015-04-30

6.  Liver metastases and SBRT: A new paradigm?

Authors:  Tiziana Comito; Elena Clerici; Angelo Tozzi; Giuseppe D'Agostino
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-06

Review 7.  Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT.

Authors:  Carlo Greco; Oriol Pares; Nuno Pimentel; Elizabeth Moser; Vasco Louro; Xavier Morales; Barbara Salas; Zvi Fuks
Journal:  Rep Pract Oncol Radiother       Date:  2015-04-18

8.  SBRT for lung oligometastases: Who is the perfect candidate?

Authors:  Pierina Navarria; Fiorenza De Rose; Anna Maria Ascolese
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-30

Review 9.  Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives.

Authors:  N H Rekers; E G C Troost; C M L Zegers; W T V Germeraad; L J Dubois; P Lambin
Journal:  Cancer Radiother       Date:  2014-08-30       Impact factor: 1.018

10.  Radiation as an immunological adjuvant: current evidence on dose and fractionation.

Authors:  Sandra Demaria; Silvia C Formenti
Journal:  Front Oncol       Date:  2012-10-26       Impact factor: 6.244
View more
  3 in total

1.  Image guided SBRT for multiple liver metastases with ExacTrac® Adaptive Gating.

Authors:  Carmen Rubio; Ovidio Hernando-Requejo; Daniel Zucca Aparicio; María ALlona Krauel; Mercedes López Gonzalez; Juan María Pérez; Emilio Sánchez Saugar; Pedro Fernández Letón
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-17

2.  On the use of AAA and AcurosXB algorithms for three different stereotactic ablative body radiotherapy (SABR) techniques: Volumetric modulated arc therapy (VMAT), intensity modulated radiation therapy (IMRT) and 3D conformal radiotherapy (3D-CRT).

Authors:  Abdulrahman Tajaldeen; Prabhakar Ramachandran; Salem Alghamdi; Moshi Geso
Journal:  Rep Pract Oncol Radiother       Date:  2019-03-23

Review 3.  Stereotactic radiotherapy for lung oligometastases.

Authors:  Lorenzo Falcinelli; Claudia Menichelli; Franco Casamassima; Cynthia Aristei; Simona Borghesi; Gianluca Ingrosso; Lorena Draghini; Angiolo Tagliagambe; Serena Badellino; Michela Buglione di Monale E Bastia
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.